Suppr超能文献

由耐利福布汀的塞拉分枝杆菌引起的肺部分枝杆菌病罕见病例及文献复习

A rare case of pulmonary mycobacteriosis caused by rifabutin resistant Mycobacterium celatum and review of the literature.

作者信息

Doktorova Demmin Marcela, Gillissen Adrian

机构信息

Department of Internal Medicine III (Internal and Pulmonary Medicine), Ermstalklinik of Kreisklinikum Reutlingen, Stuttgarterstr. 100, D-72574, Bad Urach, Germany.

出版信息

Respir Med Case Rep. 2019 Jul 8;28:100903. doi: 10.1016/j.rmcr.2019.100903. eCollection 2019.

Abstract

The present case demonstrates an atypical pulmonary mycobacteriosis that mimicked classical symptoms and radiology findings for tuberculosis. While T-SPOT Test and PCR analyses proved negative for tuberculosis, microscopic sputum evaluation showed acid-fast bacilli and was found in culture. Uniquely, in our case was resistant to rifabutin. Therefore, after not responding to combination treatment including rifabutin, our patient was treated with ethambutol, clarithromycin and protionamide. Classical risk factors for atypical mycobacteriosis such as immunodeficiency (including medication-induced), preexisting pulmonary disease or multimorbidity were not present. We conclude that the high age of the patient (92 y) may have been the main contributing factor for the infection.

摘要

本病例展示了一种非典型肺分枝杆菌病,其模仿了结核病的经典症状和影像学表现。虽然结核感染T细胞检测(T-SPOT Test)和聚合酶链反应(PCR)分析结果显示结核病为阴性,但痰涂片显微镜检查发现了抗酸杆菌,且培养结果呈阳性。独特的是,在我们的病例中,该病菌对利福布汀耐药。因此,在对包括利福布汀在内的联合治疗无反应后,我们的患者接受了乙胺丁醇、克拉霉素和丙硫异烟胺治疗。非典型分枝杆菌病的经典危险因素,如免疫缺陷(包括药物引起的)、既往肺部疾病或多种疾病并存,在该病例中均不存在。我们得出结论,患者的高龄(92岁)可能是感染的主要促成因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdf3/6626106/c6cbc26c0f18/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验